| Key Financial Ratios of Sun Pharma Advanced Research Company (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-10.64 |
-11.96 |
-7.82 |
-7.73 |
-5.77 |
|
| Diluted EPS (Rs.) |
-10.64 |
-11.96 |
-7.82 |
7.73 |
-5.77 |
|
| Cash EPS (Rs.) |
-10.30 |
-11.59 |
-6.50 |
-7.11 |
-5.35 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
-6.80 |
3.85 |
15.80 |
1.15 |
-6.42 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
-6.80 |
3.85 |
15.80 |
1.15 |
-6.42 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
2.21 |
2.33 |
7.36 |
5.05 |
9.65 |
|
| PBDIT/Share (Rs.) |
-10.03 |
-11.53 |
-6.26 |
-6.62 |
-4.94 |
|
| PBIT/Share (Rs.) |
-10.36 |
-11.91 |
-6.62 |
-6.99 |
-5.36 |
|
| PBT/Share (Rs.) |
-10.64 |
-11.96 |
-6.86 |
-7.48 |
-5.77 |
|
| Net Profit/Share (Rs.) |
-10.64 |
-11.96 |
-6.86 |
-7.48 |
-5.77 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
-453.53 |
-495.49 |
-85.09 |
-131.07 |
-51.22 |
|
| PBIT Margin (%) |
-468.62 |
-511.54 |
-90.01 |
-138.48 |
-55.53 |
|
| PBT Margin (%) |
-481.03 |
-513.73 |
-93.21 |
-148.19 |
-59.74 |
|
| Net Profit Margin (%) |
-481.03 |
-513.73 |
-93.21 |
-148.19 |
-59.74 |
|
| Return on Networth / Equity (%) |
0.00 |
-310.83 |
-43.40 |
-651.37 |
0.00 |
|
| Return on Capital Employed (%) |
756.68 |
-159.39 |
-33.00 |
-174.92 |
3,836.49 |
|
| Return on Assets (%) |
-104.84 |
-79.80 |
-26.81 |
-72.61 |
-65.80 |
|
| Total Debt/Equity (X) |
-1.17 |
0.38 |
0.00 |
2.40 |
-1.17 |
|
| Asset Turnover Ratio (%) |
0.18 |
0.11 |
0.43 |
0.54 |
110.12 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.07 |
1.01 |
2.54 |
0.42 |
0.27 |
|
| Quick Ratio (X) |
0.07 |
1.01 |
2.54 |
0.42 |
0.27 |
|
| Inventory Turnover Ratio (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
5,060.04 |
11,897.92 |
5,712.17 |
8,144.74 |
3,900.74 |
|
| EV/Net Operating Revenue (X) |
70.51 |
157.49 |
23.92 |
59.34 |
15.42 |
|
| EV/EBITDA (X) |
-15.55 |
-31.79 |
-28.11 |
-45.27 |
-30.11 |
|
| MarketCap/Net Operating Revenue (X) |
66.93 |
158.92 |
24.39 |
58.81 |
14.68 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
-21.77 |
96.16 |
11.36 |
258.49 |
-22.07 |
|
| Price/Net Operating Revenue |
66.93 |
158.93 |
24.39 |
58.81 |
14.68 |
|
| Earnings Yield |
-0.07 |
-0.03 |
-0.04 |
-0.03 |
-0.04 |
|
Source : Dion Global Solutions Limited
